For decades, Parkinson's disease has long been thought of as a brain disorder, characterized by the degeneration of dopamine-producing neurons in the substantia nigra — a region of the brain that ...

A research team led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University has made a ...

In a significant achievement for identifying neurodegenerative diseases early, a team of US researchers has developed a new ...

Parkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

A team discovered that patients with Dementia with Lewy Bodies (DLB) have significantly lower levels of α-synuclein in their ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its ...

A new study suggests Parkinson's disease may start in the kidneys. Researchers in China found abnormal protein clumps in the ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better outcomes ...

StateViewer, an AI tool, analyzes FDG-PET scans to classify nine types of dementia with 88% accuracy. Tested on over 3,600 scans, it helps clinicians diagnose dementia nearly twice as fast with three ...